Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Goldstein

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Communications in Psychopharmacology|January 1, 1977
Evaluation of naloxone in laboratory tests predictive of clinical antipsychotic activityJ B Malick, M L Billingsley, R K Kubena, et al.
Infection and Immunity|August 14, 2001
Novel extracellular x-prolyl dipeptidyl-peptidase (DPP) from Streptococcus gordonii FSS2: an emerging subfamily of viridans Streptococcal x-prolyl DPPsJ M Goldstein, A Banbula, T Kordula, et al.
Schizophrenia Bulletin|January 1, 1990
The role of gender in identifying subtypes of schizophrenia: a latent class analytic approachJ M Goldstein, S L Santangelo, J C Simpson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1989
Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activityJ M Goldstein, L C Litwin, E B Sutton, et al.
Schizophrenia Research|July 1, 1992
Gender and the familial risk for schizophrenia. Disentangling confounding factorsJ M Goldstein, S V Faraone, W J Chen, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|November 18, 2000
Severity of mood, self-evaluative, and vegetative symptoms of depression in myasthenia gravisR H Paul, R A Cohen, J M Goldstein, et al.
Psychopharmacology|January 1, 1993
Seroquel: electrophysiological profile of a potential atypical antipsychoticJ M Goldstein, L C Litwin, E B Sutton, et al.
Biological Psychiatry|December 15, 1995
Genetic heterogeneity may in part explain sex differences in the familial risk for schizophreniaJ M Goldstein, S V Faraone, W J Chen, et al.
Infection and Immunity|January 25, 2005
Characterization of an extracellular dipeptidase from Streptococcus gordonii FSS2J M Goldstein, T Kordula, J L Moon, et al.
Journal of Psychiatric Research|November 1, 1994
Are schizophrenic men at higher risk for developmental deficits than schizophrenic women? Implications for adult neuropsychological functionsJ M Goldstein, L J Seidman, S Santangelo, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Communications in Psychopharmacology|January 1, 1977
Evaluation of naloxone in laboratory tests predictive of clinical antipsychotic activityJ B Malick, M L Billingsley, R K Kubena, et al.
Infection and Immunity|August 14, 2001
Novel extracellular x-prolyl dipeptidyl-peptidase (DPP) from Streptococcus gordonii FSS2: an emerging subfamily of viridans Streptococcal x-prolyl DPPsJ M Goldstein, A Banbula, T Kordula, et al.
Schizophrenia Bulletin|January 1, 1990
The role of gender in identifying subtypes of schizophrenia: a latent class analytic approachJ M Goldstein, S L Santangelo, J C Simpson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1989
Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activityJ M Goldstein, L C Litwin, E B Sutton, et al.
Schizophrenia Research|July 1, 1992
Gender and the familial risk for schizophrenia. Disentangling confounding factorsJ M Goldstein, S V Faraone, W J Chen, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|November 18, 2000
Severity of mood, self-evaluative, and vegetative symptoms of depression in myasthenia gravisR H Paul, R A Cohen, J M Goldstein, et al.
Psychopharmacology|January 1, 1993
Seroquel: electrophysiological profile of a potential atypical antipsychoticJ M Goldstein, L C Litwin, E B Sutton, et al.
Biological Psychiatry|December 15, 1995
Genetic heterogeneity may in part explain sex differences in the familial risk for schizophreniaJ M Goldstein, S V Faraone, W J Chen, et al.
Infection and Immunity|January 25, 2005
Characterization of an extracellular dipeptidase from Streptococcus gordonii FSS2J M Goldstein, T Kordula, J L Moon, et al.
Journal of Psychiatric Research|November 1, 1994
Are schizophrenic men at higher risk for developmental deficits than schizophrenic women? Implications for adult neuropsychological functionsJ M Goldstein, L J Seidman, S Santangelo, et al.
Pageof 13